Literature DB >> 31865801

The relevance of bronchoalveolar lavage fluid analysis for lung cancer patients.

Joanna Domagala-Kulawik1.   

Abstract

Introduction: Lung cancer is a serious malignant disease with poor prognosis. The methods for improving early recognition and markers of predictive value are widely investigated. Bronchoalveolar lavage (BAL) is a valuable method of respiratory tract investigation. Currently, BAL is rarely used for tumor diagnosis, but for ruling out differential diagnosis, due to its poor sensitivity. The new indication for BAL fluid analysis is evaluation of local immune reaction in lung cancer patients and description of tumor microenvironment (TME). A literature search was performed in bibliography bases from the time of the introduction of BAL in the diagnosis of lung diseases. We analyzed our prior original studies with the bibliography.Area covered: The usefulness of BAL in the diagnosis of peripheral spread of malignant diseases and in the evaluation of TME in lung cancer, as well as a role of BAL in the diagnosis of checkpoint inhibitor pneumonitis is presented. Commentary concerning methodology of BALF analysis in lung cancer is included.Expert opinion: It seems that in the near future BAL will find an important place in the evaluation of lung cancer TME in two aspects. The first could be characteristic of immune reaction by analysis of immune cells and mediators and the second cancer molecular characteristic by free DNA and exosomes analysis.

Entities:  

Keywords:  BAL; lung cancer; tumor environment

Year:  2019        PMID: 31865801     DOI: 10.1080/17476348.2020.1708720

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  10 in total

Review 1.  Estrogens, Cancer and Immunity.

Authors:  Izabela Orzołek; Jan Sobieraj; Joanna Domagała-Kulawik
Journal:  Cancers (Basel)       Date:  2022-04-30       Impact factor: 6.575

2.  Identification of PD-1 ligands: PD-L1 and PD-L2 on macrophages in lung cancer milieu by flow cytometry.

Authors:  Iwona Kwiecień; Elżbieta Rutkowska; Małgorzata Polubiec-Kownacka; Agata Raniszewska; Piotr Rzepecki; Joanna Domagała-Kulawik
Journal:  Transl Lung Cancer Res       Date:  2021-04

Review 3.  EVs from BALF-Mediators of Inflammation and Potential Biomarkers in Lung Diseases.

Authors:  Lukasz Zareba; Jacek Szymanski; Zuzanna Homoncik; Malgorzata Czystowska-Kuzmicz
Journal:  Int J Mol Sci       Date:  2021-04-01       Impact factor: 5.923

4.  The cellular composition of the lung lining fluid gradually changes from bronchus to alveolus.

Authors:  S D Pouwels; Janette K Burgess; Erik Verschuuren; Dirk-Jan Slebos
Journal:  Respir Res       Date:  2021-11-04

Review 5.  Bronchoalveolar lavage and lung biopsy in connective tissue diseases, to do or not to do?

Authors:  Sara Tomassetti; Thomas V Colby; Athol U Wells; Venerino Poletti; Ulrich Costabel; Marco Matucci-Cerinic
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-12-08       Impact factor: 5.346

6.  NADPH oxidase 4 signaling in a ventilator-induced lung injury mouse model.

Authors:  Sang Hoon Lee; Mi Hwa Shin; Ah Young Leem; Su Hwan Lee; Kyung Soo Chung; Young Sam Kim; Moo Suk Park
Journal:  Respir Res       Date:  2022-03-27

Review 7.  Expert opinion on NSCLC small specimen biomarker testing - Part 1: Tissue collection and management.

Authors:  Frédérique Penault-Llorca; Keith M Kerr; Pilar Garrido; Erik Thunnissen; Elisabeth Dequeker; Nicola Normanno; Simon J Patton; Jenni Fairley; Joshua Kapp; Daniëlle de Ridder; Aleš Ryška; Holger Moch
Journal:  Virchows Arch       Date:  2022-07-20       Impact factor: 4.535

8.  Clinical characteristics and management of immune checkpoint inhibitor-related pneumonitis: A single-institution retrospective study.

Authors:  Hanping Wang; Yanwei Zhao; Xiaotong Zhang; Xiaoyan Si; Peng Song; Yi Xiao; Xu Yang; Lan Song; Juhong Shi; Haitao Zhao; Li Zhang
Journal:  Cancer Med       Date:  2020-11-19       Impact factor: 4.452

9.  A Preliminary Study on the Prognostic Impact of Neutrophil to Lymphocyte Ratio of the Bronchoalveolar Lavage Fluid in Patients with Lung Cancer.

Authors:  Woo Kyung Ryu; Yeonsook Moon; Mi Hwa Park; Jun Hyeok Lim; Young Sam Kim; Kyung-Hee Lee; Seung Min Kwak; Changhwan Kim; Hae-Seong Nam
Journal:  Diagnostics (Basel)       Date:  2021-11-25

10.  Characterization of Extracellular Vesicles from Bronchoalveolar Lavage Fluid and Plasma of Patients with Lung Lesions Using Fluorescence Nanoparticle Tracking Analysis.

Authors:  Magdalena Dlugolecka; Jacek Szymanski; Lukasz Zareba; Zuzanna Homoncik; Joanna Domagala-Kulawik; Malgorzata Polubiec-Kownacka; Malgorzata Czystowska-Kuzmicz
Journal:  Cells       Date:  2021-12-09       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.